Breast Cancer
Conditions
Keywords
breast cancer, Contrast-enhanced digital mammography
Brief summary
To evaluate the effectiveness of Contrast-enhanced digital mammography (CEDM) in detecting breast cancer in women at higher risk.
Detailed description
The aim of this study was to evaluate the effectiveness of different imaging techniques for detecting breast cancer in women with a higher risk due to personal or family history of the disease.
Interventions
DEVICECEDM
Women underwent CEDM screening
Sponsors
Kaohsiung Veterans General Hospital.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* women underwent CEDM screening
Exclusion criteria
* incomplete imaging exams
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total number of cases received and diagnosed with breast cancer (Number) | Up to 3 years | This refers to the total number of individuals who underwent breast cancer screening or assessment and the number diagnosed with breast cancer. Evaluating the accuracy of screening tests using measures such as true positives and true negatives is crucial for assessing the reliability of screening tests and identifying potential issues. These measures help healthcare professionals make informed decisions about screening and diagnostic strategies. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total number of cases received and diagnosed as positive requiring a biopsy and MRI (Number) | Up to 3 years | This refers to the total number of individuals who underwent breast cancer screening or assessment and tested positive, requiring a biopsy and MRI for further evaluation. A biopsy is necessary to confirm whether an individual has breast cancer. Monitoring the diagnostic accuracy of breast cancer screening tests and the number of individuals requiring further procedures is essential for determining appropriate treatment or monitoring. Measures such as true positives and true negatives are used to evaluate the accuracy of screening tests. |
| True positive results obtained by the diagnostic method (Number) | Up to 3 years | The total number of true positive results obtained by the diagnostic method, indicating the cases with breast cancer that are correctly identified. A higher number of true positives demonstrates better performance in correctly identifying cases with breast cancer. |
| True negative results obtained by the diagnostic method (Number) | Up to 3 years | The total number of true negative results obtained by the diagnostic method, indicating the cases without breast cancer that are correctly identified. A higher number of true negatives demonstrates better performance in correctly identifying cases without breast cancer and reducing false positives. |
Countries
Taiwan
Outcome results
None listed